ETON
Eton Pharmaceuticals Inc
55.40$
+6.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 37.4% | 50.4% | 37.1% | 38.0% | 39.0% | 44.4% | 42.9% | 37.0% | 65.0% | 38.4% | 39.3% | 32.4% | 42.1% | |
| 62.6% | 49.6% | 62.9% | 62.0% | 61.0% | 55.6% | 57.1% | 63.0% | 35.0% | 61.6% | 60.7% | 67.6% | 57.9% | |
| 8.8% | 14.3% | 8.2% | 32.7% | 4.9% | 7.5% | 6.7% | 19.6% | 5.0% | 8.4% | 7.7% | 2.6% | 5.5% | |
| 61.7% | 62.6% | 64.7% | 61.6% | 51.2% | 57.7% | 53.1% | 51.2% | 36.1% | 41.6% | 43.0% | 30.9% | 37.0% | |
| 70.4% | 76.9% | 72.9% | 94.3% | 56.1% | 50.2% | 59.8% | 70.8% | 41.0% | 50.0% | 50.8% | 33.6% | 42.4% | |
| -7.8% | -27.3% | -10.0% | -32.3% | 4.9% | 5.4% | -2.7% | -7.8% | -6.1% | 11.6% | 9.9% | 34.0% | 15.4% | |
| 0.4% | 4.9% | 0.1% | 0.6% | 0.1% | 11.4% | 6.7% | 6.3% | 5.4% | 5.7% | 3.5% | 2.9% | 4.1% | |
| -8.2% | -27.5% | -10.2% | -32.9% | 4.9% | -4.4% | -8.7% | -13.3% | -8.7% | 6.6% | 6.5% | 31.2% | 12.1% | |
| 3.4% | 3.4% | 2.6% | 0.6% | -1.2% | 0.7% | 0.4% | 0.3% | -0.1% | -0.3% | 0.1% | 0.4% | 0.1% | |
| -8.2% | -30.8% | -10.2% | -33.5% | 6.1% | -5.1% | -9.1% | -13.7% | -8.6% | 7.0% | 6.4% | 30.8% | 12.0% | |
| -5.1% | -34.4% | -7.1% | -29.3% | 7.6% | -1.3% | 3.9% | -1.7% | 1.2% | 17.1% | 7.7% | 34.0% | 17.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.